Correction: Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke (PLoS ONE (2017) 12:2 (e0171521) DOI: 10.1371/journal.pone.0171521);Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke

PLoS ONE

Volumn 12, Issue 2, 2017, Pages

  Yamashiro, Kazuo ^a   Tanaka, Ryota ^a   Urabe, Takao ^b   Ueno, Yuji ^a   Yamashiro, Yuichiro ^c   Nomoto, Koji ^c,d   Takahashi, Takuya ^c,d   Tsuji, Hirokazu ^d   Asahara, Takashi ^d   Hattori, Nobutaka ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

^c JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RNA 16S; RNA 23S; TRIACYLGLYCEROL;

AGED; ARTICLE; ATOPOBIUM; BRAIN ISCHEMIA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSBIOSIS; FEMALE; FERMENTATION; HEMOGLOBIN BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS RUMINIS; LACTOBACILLUS SAKEI; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 85011695835     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0176062     Document Type: Erratum

References (49)

1. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006; 444: 860-867. doi: 10.1038/ nature05485 PMID: 17167474
2. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997; 336: 973-979. doi: 10.1056/ NEJM199704033361401 PMID: 9077376
3. Welsh P, Lowe GD, Chalmers J, Campbell DJ, Rumley A, Neal BC, et al. Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke. 2008; 39: 2226-2230. doi: 10.1161/ STROKEAHA.107.504498 PMID: 18566306
4. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011; 377: 557-567. doi: 10.1016/S0140-6736(10)62037-5 PMID: 21295846
5. Cohen JD, Cziraky MJ, Cai Q, Wallace A, Wasser T, Crouse JR, et al. 30-year trends in serum lipids among United States adults: Results from the National Health and Nutrition Examination Surveys ii, iii, and 1999-2006. Am J Cardiol. 2010; 106: 969-975. doi: 10.1016/j.amjcard.2010.05.030 PMID: 20854959
6. Abraham TM, Pencina KM, Pencina MJ, Fox CS. Trends in diabetes incidence: The Framingham heart study. Diabetes Care. 2015; 38: 482-487. doi: 10.2337/dc14-1432 PMID: 25552418
7. Kubo M, Hata J, Doi Y, Tanizaki Y, Iida M, Kiyohara Y. Secular trends in the incidence of and risk factors for ischemic stroke and its subtypes in Japanese population. Circulation. 2008; 118: 2672-2678. doi: 10.1161/CIRCULATIONAHA.107.743211 PMID: 19106389
8. Harmsen P, Wilhelmsen L, Jacobsson A. Stroke incidence and mortality rates 1987 to 2006 related to secular trends of cardiovascular risk factors in Gothenburg, Sweden. Stroke. 2009; 40: 2691-2697. doi: 10.1161/STROKEAHA.109.550814 PMID: 19498188
9. Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis. 2015; 26: 26191. doi: 10.3402/mehd.v26.26191 PMID: 25651997
10. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: Human gut microbes associated with obesity. Nature. 2006; 444: 1022-1023. doi: 10.1038/4441022a PMID: 17183309
11. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature. 2009; 457: 480-484. doi: 10.1038/nature07540 PMID: 19043404
12. Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 2010; 5: e9085. doi: 10.1371/journal.pone.0009085 PMID: 20140211
13. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012; 490: 55-60. doi: 10.1038/nature11450 PMID: 23023125
14. Sato J, Kanazawa A, Ikeda F, Yoshihara T, Goto H, Abe H, et al. Gut dysbiosis and detection of "live gut bacteria" in blood of Japanese patients with type 2 diabetes. Diabetes Care. 2014; 37: 2343-2350. doi: 10.2337/dc13-2817 PMID: 24824547
15. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011; 472: 57-63. doi: 10.1038/nature09922 PMID: 21475195
16. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013; 19: 576-585. doi: 10. 1038/nm.3145 PMID: 23563705
17. Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013; 368: 1575-1584. doi: 10.1056/ NEJMoa1109400 PMID: 23614584
18. Yin J, Liao SX, He Y, Wang S, Xia GH, Liu FT, et al. Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack. J Am Heart Assoc. 2015; 4: e002699. doi: 10.1161/JAHA.115.002699 PMID: 26597155
19. Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by short chain fatty acids. Nutrients. 2011; 3: 858-876. doi: 10.3390/nu3100858 PMID: 22254083
20. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013; 54: 2325-2340. doi: 10.1194/jlr.R036012 PMID: 23821742
21. Karlsson FH, Fåk F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D, et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun. 2012; 3: 1245. doi: 10.1038/ ncomms2266 PMID: 23212374
22. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of Org 10172 in acute stroke treatment. Stroke. 1993; 24: 35-41. PMID: 7678184
23. Matsuda K, Tsuji H, Asahara T, Kado Y, Nomoto K. Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl Environ Microbiol. 2007; 73: 32-39. doi: 10. 1128/AEM.01224-06 PMID: 17071791
24. Matsuda K, Tsuji H, Asahara T, Matsumoto K, Takada T, Nomoto K. Establishment of an analytical system for the human fecal microbiota, based on reverse transcription-quantitative PCR targeting of multicopy rRNA molecules. Appl Environ Microbiol. 2009; 75: 1961-1969. doi: 10.1128/AEM.01843-08 PMID: 19201979
25. Sakaguchi S, Saito M, Tsuji H, Asahara T, Takata O, Fujimura J, et al. Bacterial rRNA-targeted reverse transcription-PCR used to identify pathogens responsible for fever with neutropenia. J Clin Microbiol. 2010; 48: 1624-1628. doi: 10.1128/JCM.01724-09 PMID: 20351213
26. Ohigashi S, Sudo K, Kobayashi D, Takahashi O, Takahashi T, Asahara T, et al. Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer. Dig Dis Sci. 2013; 58: 1717-1726. doi: 10.1007/s10620-012-2526-4 PMID: 23306850
27. Hasegawa S, Goto S, Tsuji H, Okuno T, Asahara T, Nomoto K, et al. Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's Disease. PLoS One. 2015; 10: e0142164. doi: 10.1371/journal.pone.0142164 PMID: 26539989
28. Neville BA, Forde BM, Claesson MJ, Darby T, Coghlan A, Nally K, et al. Characterization of pro-inflammatory flagellin proteins produced by Lactobacillus ruminis and related motile Lactobacilli. PLoS One. 2012; 7: e40592. doi: 10.1371/journal.pone.0040592 PMID: 22808200
29. Štšepetova J, Sepp E, Kolk H, Láivukene K, Songisepp E, Mikelsaar M. Diversity and metabolic impact of intestinal Lactobacillus species in healthy adults and the elderly. Br J Nutr. 2011; 105: 1235-1244. doi: 10.1017/S0007114510004770 PMID: 21303568
30. Abreu NA, Nagalingam NA, Song Y, Roediger FC, Pletcher SD, Goldberg AN, et al. Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis. Sci Transl Med. 2012; 4: 151ra24.
31. Lahti L, Salonen A, Kekkonen RA, Salojärvi J, Jalanka-Tuovinen J, Palva A, et al. Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data. PeerJ. 2013; 1: e32. doi: 10.7717/peerj.32 PMID: 23638368
32. Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol. 2004; 70: 7220-7228. doi: 10.1128/AEM.70.12.7220-7228.2004 PMID: 15574920
33. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011; 331: 337-341. doi: 10.1126/science. 1198469 PMID: 21205640
34. Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009; 15: 1183-1189. doi: 10.1002/ibd. 20903 PMID: 19235886
35. Kondo T, Kishi M, Fushimi T, Ugajin S, Kaga T. Vinegar intake reduces body weight, body fat mass, and serum triglyceride levels in obese Japanese subjects. Biosci Biotechnol Biochem. 2009; 73: 1837-1843. PMID: 19661687
36. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the g-protein-coupled receptor FFAR2. Diabetes. 2012; 61: 364-371. doi: 10.2337/db11-1019 PMID: 22190648
37. Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun. 2013; 4: 1829. doi: 10.1038/ncomms2852 PMID: 23652017
38. Walker AW, Duncan SH, McWilliam Leitch EC, Child MW, Flint HJ. pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol. 2005; 71: 3692-3700. doi: 10.1128/AEM.71.7.3692-3700.2005 PMID: 16000778
39. Verbeke KA, Boobis AR, Chiodini A, Edwards CA, Franck A, Kleerebezem M, et al. Towards microbial fermentation metabolites as markers for health benefits of prebiotics. Nutr Res Rev. 2015; 28: 42-66. doi: 10.1017/S0954422415000037 PMID: 26156216
40. Zhou XL, Kong XF, Lian GQ, Blachier F, Geng MM, Yin YL. Dietary supplementation with soybean oligosaccharides increases short-chain fatty acids but decreases protein-derived catabolites in the intestinal luminal content of weaned Huanjiang mini-piglets. Nutr Res. 2014; 34: 780-788. doi: 10.1016/j. nutres.2014.08.008 PMID: 25236424
41. Karlsson C, Ahrné S, Molin G, Berggren A, Palmquist I, Fredrikson GN, et al. Probiotic therapy to men with incipient arteriosclerosis initiates increased bacterial diversity in colon: a randomized controlled trial. Atherosclerosis. 2010; 208: 228-233. doi: 10.1016/j.atherosclerosis.2009.06.019 PMID: 19608185
42. Katano Y, Fujinami S, Kawakoshi A, Nakazawa H, Oji S, Iino T, et al. Complete genome sequence of Oscillibacter valericigenes Sjm18-20(T) (=NBRC 101213(T)). Stand Genomic Sci. 2012; 6: 406-414. doi: 10.4056/sigs.2826118 PMID: 23408234
43. Lam YY, Ha CW, Campbell CR, Mitchell AJ, Dinudom A, Oscarsson J, et al. Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in dietinduced obese mice. PLoS One. 2012; 7: e34233. doi: 10.1371/journal.pone.0034233 PMID: 22457829
44. Pussinen PJ, Tuomisto K, Jousilahti P, Havulinna AS, Sundvall J, Salomaa V. Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol. 2007; 27: 1433-1439. doi: 10.1161/ATVBAHA.106. 138743 PMID: 17363692
45. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008; 57: 1470-1481. doi: 10.2337/db07-1403 PMID: 18305141
46. Winek K, Meisel A, Dirnagl U. Gut microbiota impact on stroke outcome: Fad or fact? J Cereb Blood Flow Metab. 2016; 36: 891-898. doi: 10.1177/0271678X16636890 PMID: 26945017
47. Houlden A, Goldrick M, Brough D, Vizi ES, Lénárt N, Martinecz B, et al. Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production. Brain Behav Immun. 2016; 57: 10-20. doi: 10.1016/j.bbi.2016.04.003 PMID: 27060191
48. Singh V, Roth S, Llovera G, Sadler R, Garzetti D, Stecher B, et al. Microbiota dysbiosis controls the neuroinflammatory response after stroke. J Neurosci. 2016; 36: 7428-7440. doi: 10.1523/JNEUROSCI. 1114-16.2016 PMID: 27413153
49. Zupancic ML, Cantarel BL, Liu Z, Drabek EF, Ryan KA, Cirimotich S, et al. Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome. PloS One. 2012; 7: e43052. doi: 10. 1371/journal.pone.0043052 PMID: 22905200